UPC CFI 1940/2026

EP3689383 Unitary patent · CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN

Case details: Status
—
Action
Counterclaim for revocation
Category
Counterclaim for revocation
Parties: Claimants
Johnson & JohnsonOperating co.
Janssen Biotech, Inc.Operating co.
Janssen Pharmaceuticals Inc.Operating co.
Janssen-Cilag International NVOperating co.
Janssen Pharmaceutica NVOperating co.
Janssen-Cilag NVOperating co.
Janssen Biologics B.V.Operating co.
Janssen-Cilag B.V.Operating co.
Janssen-Cilag GmbHOperating co.
Janssen-Cilag SASOperating co.
Janssen-Cilag SpAOperating co.
Janssen-Cilag A/SOperating co.
Janssen-Cilag AktiebolagOperating co.
Janssen-Cilag Farmaceutica Lda.Operating co.
Legend Biotech CorporationOperating co.
Legend Biotech USA Inc.Operating co.
Legend Biotech Ireland LimitedOperating co.
Legend Biotech Belgium BVOperating co.
Representatives
Pauline Debré-Linklaters LLP
Jaan de Lange-Brinkhof
Aan de Lange-Brinkhof
Andreas Obermeier-Bird & Bird LLP
Anni Lecmann
Daan de Lange-Brinkhof
Annika Lückemann-Bird & Bird LLP
Domien Op de Beeck-Bird & Bird LLP
Respondents
2seventy bio, Inc.Operating co.
Representatives
Thomas Bolter-Mewburn Ellis LLP
Eliot Hard-Mewburn Ellis LLP
Matthew Taylor-Mewburn Ellis LLP
Amy Crouch-Mewburn Ellis LLP
Camilla Balleny-Mewburn Ellis LLP
Jean Jauss-Mewburn Ellis LLP
Alex Galbriath-Mewburn Ellis LLP
Anka Koller-Mewburn Ellis LLP
Lauren Hooley-Mewburn Ellis LLP
Liam Batty-Mewburn Ellis LLP
Thomas Polter-Mewburn Ellis LLP
Eliot Pard-Mewburn Ellis LLP
Camilla Halleny-Mewburn Ellis LLP
Jean Gauss-Mewburn Ellis LLP
Alex Galbraith-Mewburn Ellis LLP
Anka Voller-Mewburn Ellis LLP
Lauren Pooley-Mewburn Ellis LLP
Liam Hatty-Mewburn Ellis LLP
Thomas Wolter-Mewburn Ellis LLP
Eliot Ward-Mewburn Ellis LLP
Matthew Naylor-Mewburn Ellis LLP
Sean Jauss-Mewburn Ellis LLP
Lauren Woolley-Mewburn Ellis LLP
Division: Brussels LD
Judges: Samuel Granata
Marije Knijff
Anna-Lena Klein
Technology: Chemistry
Biotechnology · Pharmaceuticals
Language: —
First decided: Jun 8, 2026
Last decision: Jun 15, 2026
EPO Opposition: Boult Wade Tennant LLPAdmissible2025-12-31
Legend Biotech Ireland LimitedAdmissible2026-09-29
STRAWMAN LIMITEDAdmissible2026-09-29
Lang, SvenAdmissible2026-09-30
Keltie LLPAdmissible2026-09-30
Hampton Knowles LimitedAdmissible2026-09-30
Janssen Pharmaceutica NVAdmissible2026-09-30

How this compares

The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.

	Patent revoked	Median days to first decision
All UPC	37% (34/91)	124
Brussels LD	—	Locked
Judge Samuel Granata	Locked	Locked
Judge Marije Knijff	Locked	Locked
Judge Anna-Lena Klein	Locked	Locked

At the UPC: Janssen Group (11 cases)·2seventy bio, Inc. (2 cases)

Start 14-day free trialAlready a user? Sign in

Related cases

All proceedings on this patent

This dispute contains 1 other proceedings

UPC CFI 29/2026

Start a free trial to see how each one ended.

More cases: Brussels LD·2026

Decisions

2026-06-15
Counterclaim for revocationPublic
Summary: The Brussels Local Division issued a procedural order under R.37 RoP joining the infringement action and counterclaim for revocation to be heard jointly, and directed the Judge-Rapporteur to request allocation of a technically qualified judge to the panel. The Local Division Brussels will hear both the infringement action and the counterclaim for revocation.
Show the legal issues (3)
- Joinder of infringement action and counterclaim for revocation under R.37 RoP
- Allocation of technically qualified judge
- Joint proceedings before Brussels Local Division
2026-06-08
Counterclaim for revocationPublic
Summary: The Brussels Local Division issued a procedural order under R.37.2 RoP, announcing its intention to exercise discretion to hear the infringement action (UPC_CFI_029/2026) and the counterclaim for revocation (UPC_CFI_1934/2026 and UPC_CFI_1940/2026) jointly under Art. 33(3)(a) UPCA. The parties were given until 12 June 2026 to comment on this intended course of action, with silence treated as agreement.
Show the legal issues (4)
- R.37.2 RoP - early procedural decision by order
- Art. 33(3) UPCA - joint hearing of infringement action and counterclaim for revocation
- Art. 33(3)(a) UPCA - discretion to hear infringement and revocation together
- R.158 RoP - security for costs

Documents

ORD%28I%29_R37_UPC_CFI_029-1934_1940-2026_Signed.pdf2026-06-08EN
Procedural%20Order%20%28R.37%20RoP%29%20UPC_CFI_029-2026%20UPC_CFI_1934-2026%20UPC_CFI_1940-2026.pdf2026-06-15EN